| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |